Laurion Capital Management’s Kura Oncology KURA Stock Holding History

Laurion Capital Management’s Portfolio KURA Stock Details KURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-50,000	Closed	-$917K	–	547
2022 Q2	$917K	Sell	50,000 -67,433	-57%	-$970K	0.01%	289
2022 Q1	$1.89M	Buy	117,433 +67,433	+135%	+$974K	0.02%	216
2021 Q4	$700K	Hold	50,000	–	–	0.01%	381
2021 Q3	$937K	Buy	+50,000	New	+$942K	﹤0.01%	523
2020 Q4	–	Sell	-10,400	Closed	-$319K	–	818
2020 Q3	$319K	Buy	+10,400	New	+$230K	﹤0.01%	657
2019 Q3	–	Sell	-25,000	Closed	-$492K	–	1156
2019 Q2	$492K	Buy	+25,000	New	+$415K	﹤0.01%	700

Other funds holding KURA

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Laurion Capital Management's KURA Position: Q3 2022 in Review

Laurion Capital Management sold out of Kura Oncology (KURA) in Q3 2022, closing a stake of 50,000 shares — an estimated $917K sold.

Laurion Capital Management first reported a position in KURA in Q2 2019 and held it in 6 quarters. The position peaked at $1.89M in Q1 2022. 148 funds tracked by Wall St. Rank hold KURA as of Q3 2022.

Laurion Capital Management reported no remaining Kura Oncology position as of Q3 2022 after selling out during the quarter.
Laurion Capital Management sold 50,000 Kura Oncology shares in Q3 2022, an estimated $917K.
Laurion Capital Management first reported a position in Kura Oncology in Q2 2019 and held it in 6 quarters.
Laurion Capital Management's Kura Oncology position peaked at $1.89M in Q1 2022.
148 funds tracked by Wall St. Rank held Kura Oncology as of Q3 2022.

Based on Laurion Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.